Tue. 11 Jun 2024, 4:32pm ET
Benzinga
Earnings, News
Streamline Health Solns (NASDAQ:STRM) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is unchanged from the same period last year. The company reported quarterly sales of $4.33 million which beat the analyst consensus estimate of $4.31 million by 0.46 percent. This is a 18.79 percent decrease over sales of $5.33 million the same period last year.